FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Sep 30, 2018

---

• FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma  
  FDA Press Release, September 28, 2018
• A Privacy Work-Around for Hereditary Cancer Testing  
  N Mulcahe, Medscape, September 25, 2018
• Cancer prevention: Molecular and epidemiologic consensus  
  M Song et al, Science, September 27, 2018
• My Father’s Fight Against the Breast-Cancer Gene- My grandmother and I both survived the disease, and knowing our genetic legacy turned out to be crucial in saving him  
  P Munster, WSJ, September 28, 2018
• Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications.  
  Barros-Silva Daniela et al. Genes 2018 Aug (9)
• Fecal microbiota transplantation helps restore beneficial bacteria in cancer patients  
  NIH, September 26, 2018
• Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.  
  Rowley Simone M et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Sep
• The DNA detectives who are hunting the causes of cancer  
  K Arney, Mosaic, CNN, September 25, 2018
• Your Genetic Testing Results Can Change—Here's Why  
  E Cara, Gizmodo, September 27, 2018
• [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].  
  Nishida Toshirou et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Sep 45(9) 1223-1227